政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/71195
English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  全文笔数/总笔数 : 113303/144284 (79%)
造访人次 : 50804937      在线人数 : 823
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    政大機構典藏 > 商學院 > 統計學系 > 期刊論文 >  Item 140.119/71195


    请使用永久网址来引用或连结此文件: https://nccur.lib.nccu.edu.tw/handle/140.119/71195


    题名: The effects of omega-3 fatty acids monotherapy in Alzheimer s disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study
    作者: Chiu,Chih-Chiang;Su,Kuan-Pin;Cheng,Tsung-Chi;Liu,Hsing-Cheng;Chang,Ching-Jui;Dewey,Michael E;Stewart,Robert;Huang,Shih-Yi
    贡献者: 統計系
    日期: 2008.05
    上传时间: 2014-11-06 18:22:45 (UTC+8)
    摘要: A 24-week, randomized, double-blind placebo-controlled study was carried out to test the feasibility of using omega-3 polyunsaturated fatty acids (PUFAs) monotherapy in people with cognitive impairment and to explore its effects on cognitive function and general clinical condition in these participants. Twenty three participants with mild or moderate Alzheimer’s disease and twenty three with mild cognitive impairment were randomized to receive omega-3 PUFAs 1.8 g/day or placebo (olive oil). The data of 35 (76%) participants with at least one post-treatment visit was analyzed. There were no severe adverse effects in either group and it suggests that omega-3 PUFAs were well tolerable in this population. The treatment group showed better improvement on the Clinician’s Interview-Based Impression of Change Scale (CIBIC-plus) than those in the placebo group over the 24 week follow-up (p = 0.008). There was no significant difference in the cognitive portion of the Alzheimer’s Disease Assessment Scale (ADAS-cog) change during follow-up in these two groups. However, the omega-3 fatty acids group showed significant improvement in ADAS-cog compared to the placebo group in participants with mild cognitive impairment (p = 0.03), which was not observed in those with Alzheimer’s disease. Higher proportions of eicosapentaenoic acid on RBC membranes were also associated with better cognitive outcome (p = 0.003). Further studies should be considered with a larger-sample size, diet registration, higher dosages, comparisons between different combinations of PUFAs, and greater homogeneity of participants, especially those with mild Alzheimer’s disease and mild cognitive impairment.
    關聯: Progress in Neuro-Psychopharmacology & Biological Psychiatr32(6),1538-1544
    数据类型: article
    DOI 連結: http://dx.doi.org/http://dx.doi.org/10.1016/j.pnpbp.2008.05.015
    DOI: 10.1016/j.pnpbp.2008.05.015
    显示于类别:[統計學系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    1538-1544.pdf449KbAdobe PDF2775检视/开启


    在政大典藏中所有的数据项都受到原著作权保护.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈